Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

ALBUMIN - ANVISA Registration 10387650139

Access comprehensive regulatory information for ALBUMIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10387650139 and manufactured by DXGEN CORP.. The registration is held by CAPRICORN TECHNOLOGIES DO BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10387650139
Registration Details
ANVISA Registration Number: 10387650139
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Kit para teste U-Albumin Epithod®
Risk Class II

Registration Details

10387650139

25351194453202333

02823683000102

Company Information

DXGEN CORP.
South Korea
PT: CORÉIA DO SUL

Dates and Status

May 02, 2023

VIGENTE

09/18/2025 19:00:01